Your vision is our vision.
Our vision
Your vision is our vision.
Our vision
Your vision is our vision.
Our vision

Say Hello to...
Pioneering Treatments for Diabetic Eye Disease

THR-149 – a potent PKal inhibitor for the up to 50% of DME patients who do not respond well to anti-VEGF therapies

for investors

Learn more about Oxurion.

Let's Talk.